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FOREWORD 
 The research detailed in this thesis will be submitted to the journal Sleep, a peer-reviewed 
scientific and medical journal of the Associated Professional Sleep Societies, LLC. The thesis 
has been prepared according to the guidelines of the journal.  
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ABSTRACT 
THE EFFECTS OF AEROBIC EXERCISE TIMING ON SLEEP ARCHITECTURE 
Kimberly Rose Fairbrother, B.S., West Virginia University 
M.S., Appalachian State University 
Chairperson: Scott R. Collier 
Objectives: It is well known that the quality of sleep has direct effects on the 
manifestations of disease.  Further, exercise has been shown to enhance the quality of sleep, 
yet little is known regarding how exercise effects sleep stages.   Our laboratory has shown 
that the timing of exercise is important for cardiovascular benefits which may be derived 
from the improved quality of sleep.  Therefore, the purpose of this study was to investigate 
the effects of aerobic exercise timing on sleep architecture.  Methods: Thirteen subjects, 4 
male and 7 female, (mean age 40 ± 3 years) with no self-reported sleep disorders and not on 
any medications participated in this study. Visit one consisted of informed consent and a 
graded exercise test to exhaustion peak oxygen consumption (VO2peak) and equipment 
familiarization.  During visits 2-4 subjects reported for 3 pre-determined exercise times at 
7am, 1pm, and 7pm in a random counterbalanced order to perform a 30 minute treadmill 
protocol at 65% of their predetermined VO2peak.  A  Zeo™ ambulatory sleep 
electroencephalogram (EEG) monitoring headband was worn during sleep. This system 
transmitted brainwave data to a receiver which was analyzed for sleep stage time and quality 
of sleep. Results: Aerobic exercise at 7am invoked  significantly greater time spent in light 
and deep sleep (85% and 75% greater time in minutes, respectively, p< 0.05) and the greatest 
 vi  
frequency of sleep cycles (12% greater cycles, p< 0.05) compared to exercise in the 
afternoon or evening.  However, exercise at 7pm showed less time in Rapid Eye Movement 
(REM) sleep compared to 7am and 1pm exercise times (40% less time in minutes REM, 
p<0.05).  Conclusion: These data show that engaging in aerobic exercise during the early 
morning hours may be the most beneficial epoch of time for greater quality of sleep. 
 
vii 
 
ACKNOWLEDGEMENTS 
This thesis was completed through the support of an Office of Student Research 
Grant, a Graduate Student Association Senate Research Grant, and the ZeoTM Sleep Research 
Grant. 
 I would like to first and foremost thank my mentor and friend, Dr. Scott Collier. You 
always believed in me as a student, researcher, and person. You taught me how to be a great 
scientist and gave me confidence in myself to succeed in life.  
 Thank you to my thesis committee, Dr. David Morris and Dr. Travis Triplett, for your 
guidance, support, and friendship. The time you took to help me improve myself as a scientist 
and writer are greatly appreciated.  
 I would like to thank the graduate students in the Vascular Biology and Autonomic 
Studies lab, especially Ben Cartner and Chelsea Curry. This project would not have been 
possible without your hard work and dedication. Thank you to Tyler Kirby for your 
understanding and support, and for helping me to better understand and appreciate research. 
Also, thank you to Jared Skinner and Tracie Haines for keeping my spirits up when things were 
tough.  
 Lastly, I would like to thank my family, Mom, Dad, Jay, and Brent, for your 
unconditional love. You all have seen me grow from the little girl flipping around the house to 
the woman I am today and have supported and encouraged me every step of the way.  
 
1 
 
 
Introduction 
It has been well observed that poor sleep quality is detrimental to one’s mood, 
physical and mental performance, health, and overall quality of life.1, 2Throughout the night, 
most individuals follow a predictable, cyclic, sleep stage pattern of Non Rapid Eye 
Movement (NREM) and Rapid Eye Movement (REM) sleep. The stages of sleep have 
previously been reviewed by Kubitz et al.,3 and are classified as follows. Stage 1 sleep is 
classified as the beginning phase between awakeness and the early onset of light sleep where 
electroencephalogram (EEG) activity is at a low voltage with mixed frequencies. Stage 2 is 
when the individual becomes disengaged from the environment, body temperature begins to 
drop, but minute ventilation and heart rate stay the same. In addition, EEG activity is very 
similar to that at stage 1. Stages 3 and 4 are the deepest stages of sleep where blood pressure 
(BP) significantly drops, tissue growth and repair occurs, blood supply to muscles increase, 
and hormone secretion is at its highest. Stage 3 is characterized by high amounts of high 
amplitude and slow wave activity, while stage 4 is characterized by even larger amounts of 
high amplitude and slow wave activity on an EEG. Following stage 4 is the REM stage 
where the eyes are constantly darting back and forth while the brain remains active. During 
this period, a relatively low voltage is seen with mixed frequency EEG. According to the 
National Sleep Foundation (NSF), good sleep quality is considered when one can experience 
all of the sleep stages necessary to reap the restorative and energizing benefits of sleep.4  
Previous studies have suggested that increased amount of time in deep sleep;1, 5 decreased 
sleep onset latency;1, 6 decreased time spent in light sleep;1 and a decreased number of 
awakenings after the onset of sleep,1 independent of total sleep time, all correlate to a better 
subjective sleep quality.  
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Poor sleep quality, specifically less that 6-7 quality hours per night, correlates to 
clinical manifestations such as hypertension,7-11 stroke,12 obesity,11, 13other cardiovascular 
consequences,11 and ultimately an increased risk of mortality.12 Hypertension is a significant 
modifiable risk factor for stroke, coronary artery disease, end-stage renal disease, and 
congestive heart failure;14-16 and detection and control of high BP is crucial to the prevention 
of these outcomes.14 The risk of cardiovascular disease increases as BP rises above 115/75 
mmHg, and this risk doubles with each 20/10 mmHg increase.17 A large cohort study done 
by Gangwish et al.8 reported that short sleep duration is likely to have direct effects on the 
risk for the incidence of hypertension independent of its influence on body weight. In 
comparison, Javaheri et al., 9 compared sleep efficiency to sleep duration and the prevalence 
of hypertension.  After an adjustment for sex and obesity, poor sleep efficiency was 
associated with average increases in systolic BP of 4 mmHg.9 Short sleep duration was also 
associated with a 2.5- fold increase in odds for developing prehypertension (systolic BP 
(SBP) 120-139 and diastolic BP (DBP) 80-89 mmHg18), but short sleep duration was most 
directly related to poor sleep quality. Therefore, poor sleep quality may be more directly 
related to hypertension than short sleep duration.   
Youngstedt and Kline 19 stated that daytime exercise is a leading factor associated 
with the best  quality night-time sleep.  Moreover, the National Sleep Foundation 
recommends exercise as a non-pharmacological intervention of improving sleep quality. The 
definition of exercise during the daytime hours is any fatiguing activity that in turn results in 
a greater metabolic requirement for compensatory night-time sleep.20 Sleep researchers have 
predicted that duration and quality of sleep are higher in physically fit individuals, especially 
on nights following exercise perturbations. 3 Additionally, Brand et al.,6 found that 
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adolescent athletes reported better sleep patterns as well as psychological functioning when 
compared to sedentary controls. Through a meta-analysis review by Kubitz et al.,3 it was 
reported that exercise increased the total sleep time; times in stages 3 and 4, and decreased 
sleep onset latency. Previous studies have documented that aerobic exercise, specifically, is 
associated with the decreases in light stages of sleep as well as the increases in the deeper 
most restorative stages of sleep.19, 21, 22  
Aerobic exercise is currently recommended as a modality for decreasing 
cardiovascular risk by decreasing resting BP. An acute, moderate intensity aerobic exercise 
bout elicits a post-exercise hypotension effect which resets the baroreflex to lower operating 
pressures.23-25 These lower BPs are observed for up to 24-hours in hypertensive individuals.26 
No previous literature has used objective measures with a comparison of various exercise 
times to look at possible differences in overall sleep quality. Aerobic exercise contributes to 
numerous health benefits including improved sleep quality, but there is limited data 
examining exercise timing and how this may augment its effects on sleep stages. There may 
be important timing considerations due to the physiological responses elicited by a bout of 
aerobic exercise. Therefore, the purpose of our investigation was to examine how aerobic 
exercise timing affects the quality of sleep. We hypothesized that exercise at 7pm would 
elicit more favorable changes in sleep architecture than exercise at 7am or 1pm in accordance 
with the post exercise hypotension response.  
Methods 
Subjects 
Thirteen prehypertensive men and women (SBP range of 120-139, DBP 80-89 
mmHG) between the ages of 30 and 60 years old were recruited from the local community. 
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No subjects had a self-reported sleep disorder, and all were non-smokers and were not on any 
medications, including aspirin therapy or sleep aids as identified in health and activity history 
questionnaires. Investigators reviewed the screening questionnaire to ensure subjects met the 
required guidelines of the study. The investigation was approved by the Institutional Review 
Board of Appalachian State University (Appendix A).  
Experimental Design 
  Subjects reported to the laboratory on four separate occasions. On the first visit, each 
subject completed a written informed consent as well as a physical activity/health history 
questionnaire (ACSM; Appendix B). Age, height, weight, and blood pressure were all 
recorded, followed by an assessment of peak aerobic capacity. Each subject performed a 
graded treadmill exercise test to volitional exhaustion while expired air was collected and 
analyzed to determine peak oxygen uptake (VO2peak
During visits two, three, and four, participants completed the randomized aerobic 
exercise protocol at either 7 AM (7A), 1 PM (1P), or 7 PM (7P). An average washout period 
of 72 hours was allotted between subsequent exercise sessions which all took place during a 
weekday (Monday, Thursday, Monday).  Subjects were asked to refrain from alcohol and 
caffeine 12 hours prior to each exercise session and for the 24-hours following data 
collection. Following each exercise session, participants wore an ambulatory blood pressure 
device (SunTech Medical Oscar 2, Morrisville, NC) for the next 24 hour period as well as an 
ambulatory sleep monitoring system (ZeoTM, Newton, MA) on the nights following exercise.  
Subjects were instructed to maintain the same time to bed and time to wake following each 
exercise bout in order to control for total sleep time.  
). Additionally, subjects were 
familiarized with all of the data collection equipment utilized within the study.  
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Maximal aerobic capacity 
VO2peak
Exercise protocol 
 was assessed using a customized treadmill protocol (Modified Armstrong 
protocol). Intensity started at 2.5 miles per hour (mph) and increased by 1 mph every two 
minutes until a comfortable pace was established at which point the test began. If additional 
intensity was required, the grade of the treadmill was increased (2.5%) at two-minute 
intervals until volitional fatigue was reached. Heart rate was recorded once per minute during 
the protocol, and a minimum of four minutes into recovery, using a Polar Heart Rate Monitor 
(Polar Electro Inc., Woodbury, NY). Ratings of perceived exertion (RPE) were also assessed 
within the last 15 seconds of each stage. Expired gases were analyzed using a True One 
metabolic system (Parvo Medics, Sandy, UT). Exercise capacity was assessed by exercise 
time and total workload expressed in metabolic equivalent of task (METS). Maximal effort 
was considered reached when the subjects met the three following criteria: no change in heart 
rate with a change in workload, a final RPE of 10 or maximal exertion, and a respiratory 
exchange ratio (RER) > 1.14. A 12-lead electrocardiogram (EKG) was used to monitor the 
test for men and women greater than 45 and 50 years of age, respectively. 
Values attained from the preliminary exercise testing session were used to design the 
aerobic exercise prescription. All individuals performed a 30 minute, aerobic exercise bout 
on a motorized treadmill at an intensity corresponding to 65% of their heart rate (HR) 
matching at their VO2peak. HR was monitored throughout every 30 minute session using a 
Polar Heart Rate Monitor to ensure subjects remained at 65% of their corresponding VO2peak
 
.  
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Ambulatory blood pressure measurement (ABPM) 
Upon completion of each exercise session, subjects were outfitted with a SunTech 
Medical Oscar2 ambulatory blood pressure device. The device was programmed to take 
oscillatory blood pressure measurements every 20 minutes throughout the 24-hour post-
exercise time and every 40 minutes during sleep. Data was stored within the device until it 
was later uploaded onto the laboratory computer.  
Ambulatory sleep stage measurement 
On nights following the completed exercise sessions, subjects wore a ZeoTM 
ambulatory sleep monitoring headband. The system consists of a soft headband (metallic 
fibers woven into the material) and a bedside display. The two-piece system utilizes dry 
sensor EEG technology to transmit brainwave data wirelessly to the bedside display where it 
was stored for later analysis. The ZeoTM system has been validated against an in-laboratory 
polysomnography and shown to be an accurate and easy way to measure sleep stages.27  
Treatment of the data 
A 1 x 3 univariate repeated measures analysis of variance was employed to determine 
the differences between exercise time and each outcome variable. If a significant interaction 
was detected, then a Bonferroni post-hoc correction was applied to determine the level of 
pairwise comparison. Data were analyzed by SPSS version 15 (SPSS, Chicago, IL). All data 
are shown as mean ± standard error (SEM). 
Results 
Subject characteristics are shown in Table 1. The subjects were classified as 
prehypertensive (BP > 120/80 mmHg) and overweight (BMI > 25). Each subject performed 
each time-of-day exercise bout. Aerobic exercise timing has distinct effects on several 
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components of sleep quality. In the nights following each exercise bout, there was no 
significant difference in total sleep time. This allowed for the comparison of absolute 
differences in the various components of sleep architecture amongst the separate exercise 
timing bouts.  
Sleep variables 
Time spent in deep sleep was significantly altered by the time of exercise (p=0.008; 
Figure 1). More time was spent in deep sleep at the 7A (63.385 minutes ± 6.133) time point 
than at 1P (43.000 minutes ± 3.193; p=0.008). Time spent in REM sleep was also 
significantly altered by the time of exercise (p=0.038; Figure 1). The bout of exercise at 7A 
presented significantly less time spent in REM sleep (98.231 minutes ± 12.945) than at 1P 
(117.462 minutes ± 12.468; p=0.050). Exercise timing had no significant effects on time 
spent in light sleep, although it followed a comparable trend (Table 2).  
Exercise timing significantly altered sleep onset latency (p =.001), with 7A resulting 
in decreased latency (11.250 minutes ± 2.471), than either 1P (32.833 minutes ± 4.024; 
p=0.001) or 7P (21.333 minutes ± 3.003; p=0.001; Figure 2). Partaking in the 7P exercise 
bout also elicited less time to sleep onset than exercising at 1P (p =0.002). Awakenings after 
the onset of sleep were significantly changed with exercise timing (p= 0.018; Figure 3). With 
the 7A exercise there were a decreased number of awakenings (3.462 ± 0.637) when 
compared to 1P (5.923 ± 0.625; p=0.021) and 7P (5.308 ± 0.444; p=0.016). Time spent in 
wake after sleep onset was not significantly different between exercise time points (Table 2). 
Discussion 
The present study investigated the effects of aerobic exercise timing on the quality of 
sleep via the comparison of time spent in deep, light, and REM sleep, as well as sleep onset 
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latency, and the number of awakenings. Contrary to our hypothesis, the main finding was 
that a bout of moderate intensity aerobic exercise at 7A improved overall sleep quality more 
so than exercise at 1P or 7P. Exercise completed at the 7A time point elicited more time 
spent in deep sleep, less time spent in REM sleep, shorter sleep onset latency, and decreased 
number of awakenings following the onset of sleep. Our findings coincide with a review 
conducted by Kubitz et al.,3 that presented the effects of acute and chronic exercise on sleep. 
They reported increases in deep sleep, and decreases in sleep onset latency, REM sleep, and 
wake time following acute and chronic exercise which correlate to an improved subjective 
sleep quality. Our study was novel in the aspect of comparing exercise timing to these 
effects.  
The deep stages of NREM sleep, represent cortical recovery from wakefulness,28 
heightened neurophysiological restoration,29 and increased physiological recuperation in 
muscle and tissue.3 Since prior amount of awake time is directly related to the amount of 
deep sleep, controlling for this in the current investigation allows for the delineation of the 
effect of the exercise bout on subsequent deep sleep. Sleep is a period of reduced metabolic 
requirements essential to energy conservation and tissue restoration. In support of energy 
conservation during sleep, findings have suggested that deep sleep will increase as a result of 
increased daytime energy expenditure where exercise is the sole stimulus to deplete energy 
stores.30 Likewise, we see a decrease in deep sleep during periods of restricted energy intake 
and weight loss.31 It is commonly found that exercise increases levels of deep sleep, 3, 30 but 
there are variances among the type of exercise performed. Aerobically trained athletes have 
higher amounts of deep sleep when compared to anaerobic athletes.32 Also, previous 
literature that shows an increase in deep sleep after exercise only show this after moderate 
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bouts of aerobic exercise and not with resistance exercise.30, 32, 33  It was recently shown that 
30 minutes of high-intensity aerobic exercise 3-4 hours prior to bed time elicited increased 
deep sleep in children compared to a baseline night of no exercise,21 and vigorous late-night 
exercise just 2 hours prior to the onset of sleep was shown to increase deep sleep and light 
sleep as well.34 Previous literature has focused on a single time of day for exercise and found 
that after both moderate and high-intensity exercise there were resultant increases in deep 
sleep.20, 30 Our results are consistent with similar studies, but analysis of exercise timing 
revealed that deep sleep was significantly higher following the 7A exercise bout when 
compared to the 1P and the 7P times. Several physiological factors may have contributed to 
this finding; however, the limited evidence regarding the biological factors that control deep 
sleep only allow for the discussion of the possible underlying mechanisms to remain purely 
speculative.  
A significant reduction in REM sleep is generally seen following exercise 
conditions,20, 30 and this reduction is greater with longer exercise bouts.20 The implications of 
decreased REM sleep in regards to sleep quality remains unclear. The timing of deep sleep is 
coupled to sleep onset, but the timing of REM sleep is potentially governed by the circadian 
system.20, 35Therefore, exercise may alter and delay the circadian rhythm phases seen in 
humans.20 Alternatively, there may be a compensatory mechanism for the increases in 
NREM sleep seen in response to exercise. Our results showed a larger decrease in REM sleep 
at 7A than at 1P or 7P, which coincides with the increased deep sleep and light sleep that was 
seen.  
Sleep onset latency (SOL) drastically shortened at the 7A time point, but was also 
significantly decreased at 7P when compared with 1P. Previous studies have reported 
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inconsistent findings on SOL, but mostly when exercise was during the late-evening hours. 
Youngstedt et al.,20 reported an increase in SOL if exercise was performed within 4 hours of 
bed time, but several other studies have shown a decrease in SOL when exercise was 
performed within this time period at various intensities.21, 34 A high-intensity cycling bout 
performed for 30 min within the 2 hours prior to sleep time showed a shortened SOL,34 
concurring with the results found with high-intensity exercise in children.21 To our 
knowledge, no other studies have compared SOL between several different exercise time 
points within the day. Previous literature on SOL tends to focus on high-intensity exercise in 
the hours just prior to bed time. Our results show that aerobic exercise in the morning hours 
improves SOL more so than evening exercise.  
Mechanisms regarding the beneficial effects of exercise on sleep are speculative, but 
have been correlated to energy conservation, tissue restitution, and temperature 
downregulation.21, 30, 34 Temperature downregulation from the anterior hypothalamus in 
response to exercise-induced body heating has been the most accepted hypothesis,34, 36 but 
lacks support in the literature. Therefore, hormonal influences may be responsible for 
improved sleep quality at 7A and 7P when compared to 1P. Dietary changes, energy 
expenditure, and specific hormonal factors such as insulin and cortisol expression alter the 
release of leptin. Schmid et al.37 reported an increase in deep sleep with a concomitant 
increase in leptin levels, suggesting a possible relationship between leptin and sleep quality.  
As previously stated, deep sleep correlates to energy intake and energy expenditure, both of 
which are known to be regulated by circulating levels of leptin. Single bouts of acute exercise 
have differing effects on leptin concentrations. When trained rowers were put through 30 
minutes of a maximal rowing, exercise leptin levels significantly declined immediately. 38 
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Additionally, after trained males underwent a running protocol for 60 minutes at 70% of their 
VO2 peak 39, leptin concentrations were decreased at both 24-hours and 48-hours post exercise.  
None of the aforementioned studies reported leptin concentrations throughout the entire day 
and night following exercise or when compared to a non-exercise day. The secretion of leptin 
follows a pulsatile fashion, with its highest levels in the evening and early morning hours.40,41 
Therefore, the timing of exercise may alter the pulsatile secretion of leptin and should be 
further researched in respects to sleep architecture.  
Conclusions and implications 
The present study indicates that partaking in a moderate bout of aerobic exercise in 
the early morning (7A) changes several aspects of sleep architecture and results in an 
improvement in overall sleep architecture. As one approaches middle age, research 
consequently finds decreases in the deep stages of sleep with concomitant increases in the 
lighter stages and a longer period of sleep onset.42-44 To date, there are no well accepted 
nonpharmacological or pharmacological interventions to increase the amount of deep sleep. 
45 Thus, utilizing aerobic exercise may be a non-pharmacological way to attenuate these 
alterations and improve sleep quality as one ages. The present investigation depicts that the 
timing of exercise is an important aspect to maximize these effects. It seems that the effect of 
exercise on the various components of sleep architecture is a complicated phenomenon 
involving several physiological aspects. Future research should focus on the mechanisms 
involved. In conclusion, aerobic exercise in the early morning (at 7A) may be the most 
beneficial time of day for better sleep quality.  
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Table 1: Subject Descriptive Characteristics. (Mean ± SEM) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age 
(years) 
Height (cm) Weight (kg) BMI (kg/m2) VO2 BP (mmHg)  (mL/kg/min) 
 
 
40 ± 3 173 ± 2.2 75 ±3.2 25 ± 2.5 40 ± 3.3 133/80 ±   
3.14 
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Table 2. Light Sleep and Wake Time compared to time-of-day exercise. P-value represents  
the result of the repeated measures ANOVA.  (Mean ± SEM) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  7A 1P 7P p-
value 
Light Sleep 
(min) 
260.385±17.522 274.769±13.484 266.615±11.725 0.67 
Wake Time 
(min) 
16.385±5.334 28.385±6.925 20.538±4.483 0.29 
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Figure 1. Time spent in Deep and REM Sleep compared to each time-of-day exercise bout. * 
denotes 7AM significantly different from 1PM (p<0.05). ** denotes 7AM significantly 
different from 1PM (p<0.01). (Mean ± SEM) 
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Figure 2. Time of Sleep Onset Latency compared to each time-of-day exercise bout. ** 
denotes 7AM significantly different from both 1PM and 7PM (p<0.01). # denotes 7PM 
significantly different from 1PM (p<0.01).  (Mean ± SEM) 
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Figure 3. Number of awakenings after the onset of sleep. * denotes 7AM significantly 
different from 1PM (p<0.05). (Mean ± SEM) 
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APPALACHIAN STATE UNIVERSITY  
Official Use Only _____-____ 
 
REQUEST FOR REVIEW OF HUMAN PARTICIPANTS RESEARCH 
 
Please complete and send the form electronically to irb@appstate.edu.  The first page with 
signatures must be submitted to IRB, Research & Graduate Studies, John E. Thomas Building. 
 
1.  Date:
 
  1   /  27    /_10__ 
2.  Project Title: The effects of exercise timing on sleep hemodynamics and behavior. 
 
3.  Principal Investigator(s): Dr. Scott Collier, Dr. David Dickinson 
 
4.  Phone: x7145  (Collier)    
 
  Email: colliersr@appstate.edu      
5.  Academic Department/Unit:  HLES 
 
(Collier)    Economics (Dickinson)    
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6.  ASU Status: Faculty/Staff X      
          
  Graduate Student          Undergraduate Student             Other   
7.  If student, name of faculty mentor:          
 
8.  Faculty mentor’s e-mail address:          
                             
                                             Phone:          
                                      
 
9.  This is: Honors or Master’s Thesis             Capstone or Project of Learning              Dissertation   
         Faculty Research                  Other ________________________   
 
 
10.  Project Support:   X 
 
  Non-Sponsored 
                                       Sponsored:       Sponsor    Proposal #    
                                                                  Pending              Funded      
 
11.  Plan to publish or present off-campus:  Yes    X       
 
           No   
12.   Projected data collection dates:  2   /25   /10         to 
 
  10 /15  / 2010_____     
13. Does this research involve any out-of-country travel?      Yes                No 
   
X  
 Proposals cannot be considered until the researchers have completed the online CITI Training 
(http://www.citiprogram.org/default.asp?language=english) required for human subject research.   
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I have read Appalachian State University’s Policy and Procedures on Human Subjects Research and 
agree to abide them.  I also agree to report any significant and relevant changes in procedures and 
instruments as they relate to participants to the Chairperson of the Institutional Review Board. 
 
 
 
_________________             _2/05/2010 _          _________________              ___________                  
PI                                                   Date                      Co-investigator                          Date 
_________________             ___________          _________________              ___________ 
PI      Date                       Co-investigator                          Date 
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CHECKLIST FOR RESEARCH INVOLVING HUMAN PARTICIPANTS 
 
 
1. Purpose of proposed research: 
 Blood pressure (BP) and the incidence of hypertension increases with age. 
Hypertension is the most prevalent cardiovascular disease that afflicts the elderly 
population and hypertension-associated cardiovascular disease is the leading cause of 
morbidity and mortality in the Western world.  It is well established that nocturnal dipping 
of blood pressure is a healthy adjustment and helps reset the bodies sensitivity to their 
blood pressure range.  Clinically, if an individual with resistant hypertension does not realize 
a dip in blood pressure at night, they show an exponential  increase in mortality and 
morbidity and a decrease in life expectancy. 
 Currently, our lab has shown a post-exercise hypotensive (PEH) response, or the 
decrease in blood pressure following a bout of exercise.  This PEH is an important 
physiological event as it helps reset the baroreflex to lower operating pressures, lending 
clinical benefit to a population with elevated blood pressure.  While a moderate-intensity 
aerobic exercise bout leads to PEH, the magnitude and length of PEH is not well established. 
 Therefore, the purpose of this study is to investigate the time course and magnitude 
of PEH on the nocturnal blood pressure response in unmedicated pre-hypertensive men and 
women.  A secondary objective of this study will be to evaluate post-exercise behavioral 
(i.e., decision-making) effects by administering a set of decision experiments to subjects at 
baseline, end-of-study, and following one bout of exercise. 
 
2. Briefly describe your subject population.  Will any individuals be excluded solely on the basis 
of gender, race, color, or any other demographic characteristic?  If so, please explain. 
 Our subject population will consist of 30-60 yr. old prehypertensive (systolic blood 
pressure range of 120-139, diastolic 80-89 mmHg) males and females, with no self-reported 
sleep disorders.  All subjects will be non- medicated, including aspirin therapy.  No subjects 
will be discriminated based on any demographic characteristic. 
 
3. Give a brief description of your research procedures as they relate to the use of human 
participants.  This description should include, at least, the following: 
Procedures: 
• Name and description of data gathering instrument (attach copy, if applicable) 
• How will the data be collected?  (e.g., audio, video, written records) 
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• Sample size 
• How long will the procedures take? 
• What, if any, relationship exists between the researcher(s) and the participants? 
• What, if any, relationship exists between the researcher(s) and the agencies (e.g., schools, 
hospitals, homes)?   
• Attach statement of approval from any agencies (e.g., schools, hospitals, homes) that will be 
involved with recruitment of participants or data collection. 
 
Individuals from the Appalachian State University greater community will be recruited for this study.  
This population will not have more than one risk factor identified by the ACSM guidelines and using 
the attached form “Screening Questionnaire”, therefore this is a relatively safe population to 
undertake 3 moderate intensity exercise bouts. The Investigators will review the screening 
questionnaire and medical health questionnaire to identify and exclude participants with more than 1 
risk factor (Screening Questionnaire, See attached .pdf).  Risk factors include: men aged 45 years or 
older, women aged 55 years or older,Essential Hypertension, Diabetes, hypercholesterolemia, 
coronary artery disease, history of myocardial infarction or stroke or a present cigarette smoker.   
All individuals will be provided with a supervised moderate intensity (walking or jogging on a 
motorized treadmill at 65% of their HR matching 65% of their VO2peak
Justification of Sample Size and Treatment of the Data 
 ) aerobic exercise bout that will 
be performed at the Vascular Biology and Autonomic Studies (VBAS) Laboratory located within the 
Institute for Health and Human Services.  If an individual has an inappropriate blood pressure 
response as outlined by the American College of Sports Medicine Guidelines, we will discontinue them 
from the study and have them report to their physician immediately. To avoid diurnal variation, all 
measurements will be repeated at the same time of day in the postprandial state (> 3 hours) and in 
the same order as the pre-measurements.  Subjects will be instructed to refrain from alcohol and 
caffeinated product consumption for 12 hours prior to testing. 
A power calculation was conducted to estimate the minimum sample size necessary to provide 
adequate statistical power to detect possible statistically significant differences between groups as 
well as training effects and training by group interactions.  This study was powered by 2 dependent 
variables, (a. pulse wave velocity, b. PEH BP response).  Based on existing data from our laboratory 
(Collier et al. In Press, JSCR 2010),  the estimated sample size of 32 subjects gives us an effect size of 
0.82 and 0.84, respectively, with an alpha set at 0.05.  Statistical power calculations were performed 
using SamplePower 2.0 (SPSS, Inc., Chicago, IL)  For blood flow data, area under the curve above 
baseline values will be calculated using GraphPad Prism 3.02 (San Diego, CA) and the trapezoidal rule 
on the basis of actual datum points above baseline flow.  Further statistical calculations will be 
performed with SPSS v17 (SPSS, Inc., Chicago, IL). A 1 x 3 ANOVA with repeated measures [exercise 
by time (morning, noon and night)] will be employed on all dependent variables.  If a significant 
interaction is detected, an appropriate post hoc test will be conducted to determine where the 
significant change in the dependent variable occurred.   
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Equipment to be used 
All subjects will perform all 3 exercise bouts following our baseline assessment. 
On visit 1, Subjects will provide written consent, complete a physical activity/health 
questionnaire (ACSM approved), and height and weight will be recorded.  Body 
composition will be assessed using the Tanita scale (bioelectrical impedence, BIA)  
system.  Subjects will then be given a randomized exercise time for their first through 
third exercise visits. A graded exercise test to volitional exhaustion with metabolic 
measurements will be completed after a body composition analysis is finished.  For 
objective verification of sleep and sleep-staging, subjects will also wear a wrist-based 
actigraphy and ambulatory sleep stage monitor during each evening of the study. 
Visit 1 
Body Composition Testing.  We will use a bio-electrical impedence scale by Tanita to 
determine body composition. Body weight will be measured to the nearest 0.01 kg 
using a calibrated laboratory electronic scale.  The subject will stand on the scale for 
approximately one minute at which time the computer will calculate reactance and 
resistance which gives the researcher an estimate of body composition. 
Maximal Exercise Testing.  Aerobic capacity will be assessed using a customized 
treadmill protocol.  Briefly, intensity will start at 2.5 mph for two minutes and increase 
by 1 mph every two minutes until a comfortable pace is established.  If additional 
intensity is required, the grade of the treadmill will be increased (% 2.5) at two-minute 
intervals until volitional fatigue is reached.  Heart rate will be recorded once per 
minute during the protocol, and a minimum of four minutes into recovery, using a 
Polar Heart Rate Monitor (Polar Electro Inc., Woodbury, NY).  Expired gases will be 
analyzed using a MedGraphics Ultima breath-by-breath metabolic system.  Exercise 
capacity will be assessed by exercise time and total workload expressed in MET.  A 12-
lead EKG will be used to monitor the test for men and women greater than 45 and 50 
years of age, respectively.   
 
Ambulatory Blood Pressure Measurement (ABPM). 
Upon completion of each exercise session, the subject will be outfitted with a SunTech 
Medical Oscar2 ambulatory blood pressure device.  This device will take oscillatory 
blood pressure measurements every 20 minutes throughout the 24-hour post-exercise 
time and every 40 minutes during sleep.  The data will be stored in the device for later 
uploading to the VBAS computer. 
Wrist worn actigraphy and ambulatory sleep staging (head-band based dry EEG 
device) 
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Though overlap exists in the measurements provided by these two devices, the 
ambulatory sleep-stage monitor is newer technology still at the validation stage, which 
is why subjects will also generate a basic sleep scoring variable with well-validated 
actigraphy technology 
Actigraphy:  The actigraphy used (Actiwatch 64®, Minimitter (now Phillips Respironics)) 
is an accelerometer with sensitivity of .05 g-force, worn on the non-dominant wrist to 
measure its activity as a proxy for gross motor activity.  At user-selected sampling 
epoch length of 30-seconds, the device can record over 3 weeks of data.  The device 
has battery life of 6 months and is also water-proof to 1-meter depth for 30 minutes, 
and so it can be worn 24-hours a day in most cases.  For our study, subjects will only 
wear at night during attempted sleep episodes.  The actigraphy data will be scored 
using the manufacturer’s software, which scores each 30-second epoch as either sleep 
or wake.  Thus, we generate an objective measure of total sleep time based on a 
validated algorithm [Oakley, 1997 “Validation with polysomnography of the Sleep-
watch sleep/wake scoring algorithm used by the Actiwatch activity monitoring system.”  
Technical Report to Mini Mitter, Co., Inc.].   
Ambulatory sleep stage measurement:
Each subject will be instructed on the use of the ambulatory blood pressure device and 
sent home with a pre-programmed device.  Each subject will return the device the 
following day and given further study instructions at that time. 
  During attempted sleep episodes, subjects will 
also wear the ZeoTM ambulatory sleep monitoring headband.  The two-piece ZeoTM 
system includes a soft headband (metallic fibers woven into the material) and bedside 
display.  The system utilizes dry sensor EEG technology to transmit brainwave data 
wirelessly to the bedside display that doubles as a clock-radio.  Though still in 
validation stage, the device has promise of generating data on distinct sleep phases 
(e.g,., slow wave, REM, light sleep) that the actigraphy is incapable of generatin.  An 
initial validation study for the ZeoTM system is: Shambroom JR, Johnstone J, Fabregas 
SE. Evaluation of a portable monitor for staging sleep. Sleep. 2009;32 (Suppl.):A386. 
Abstract 1182. 
The second, third and fourth visit will consist of the following resting measurements; 
Sphygmacor Cardiovascular Management System 
Arterial Pulse Wave Velocity and Aortic Blood Pressure Waveforms  (PWV, ABPW 
respectively).  All measurements will be conducted in accordance with guidelines set 
forth by the Clinical Application of Arterial Stiffness, Task Force III.  The applanation 
tonometer  (Sphygmacor, Sydney, Australia) will be used to derive the ascending aortic 
blood pressure waveform and a range of central arterial indices.  The Sphygmacor is 
used with a tonometer over a radial artery calibrated with a standard cuff blood 
pressure measurement.  Also we will use the PWV (measure of arterial distensibility) 
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module of the Sphygmacor to obtain indexes of arterial stiffness.  The Sphygmacor 
system is used to obtain the pulse wave between: (1) left common carotid artery and 
the left femoral artery, and (2) between the left femoral and the ipsilateral dorsalis 
pedis pulse (3) between the left common carotid artery and the left radial artery.  
Distance from the carotid sampling site to the mid point of the manubrium sterni, 
manubrium sternum to femoral artery, and femoral artery to dorsalis pedis will be 
measured between these points as straight lines with a tape measure.  The distance 
from the carotid artery to the manubrium sterni will then be subtracted from the 
manubrium to femoral artery distance PWV will be determined from the foot-to-foot 
flow wave velocity.  The foot of the pressure wave will be identified visually as the 
point of systolic upstroke.  The time delay between a minimum of 15 simultaneously 
recorded flow waves will be averaged.   PWV will then be calculated from the distances 
between measurement points and the measured time delay (Dt) between proximal and 
distal foot waveforms as follows: PWV = D / Dt (m/s); where D is distance in meters and 
Dt is the time interval in seconds.  Values attained from carotid to femoral artery will 
be taken as an index of central compliance while values attained from the carotid and 
radial artery along with the measurement from the femoral to dorsalis pedis will be 
taken as an index of peripheral compliance.  All data will be stored and analyzed off-
line after completion of testing. 
Finometer Beat to Beat Blood Pressure Machine 
Blood Pressure Variability (BPV).  Beat-to-beat blood pressures will be measured using 
finger plethysmography (FMS, Amsterdam).  Blood pressure peaks will be detected via 
an established spectral peak detection algorithm.  The sequence of the systolic peaks 
will then be interpolated to provide a continuous data stream, and the resulting 
systolic peak data detrended using a robust locally weighted regression procedure.  
The resulting data are split in sections, and each section is tapered using a split cosine 
window.  Finally, Fast Fourier transform algorithms will be used to convert the data 
into frequency spectra and smoothed across blocks of frequencies to produce a 
spectrum.  The power of the systolic peaks is calculated by measuring the area under 
the peak of the power spectra.  Power spectra within the 0.04 – 0.15 Hz range are 
defined as low-frequency components and are considered to be representative of 
sympathetic vasomotor modulation. 
Finometer Beat to Beat Blood Pressure Machine 
Baroreflex Sensitivity (BRS).  Spontaneous BRS will be derived via the sequence 
method.  With the subjects in a supine position, R-R intervals will be recorded for 10-
minutes as described above.  Beat-to-beat blood pressure will be ascertained via the 
Finometer (FMS, the Netherlands).  The spontaneous baroreflex response will be 
determined from the Beat-to-beat changes in the R-R interval and systolic blood 
pressure (SBP) by a modification of the technique of Bertinieri, et al.  Any episodes of 
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three or more consecutive heartbeats in which R-R interval and the corresponding 
(SBP) change in the same direction (either up or down) will be recorded.  The slope of 
the regression line for each episode will be calculated and the mean slope taken as an 
index of BRS.  If the observed correlation coefficient is not statistically significant, 
results are discarded.  In our lab, values <0.8 are not accepted. 
Hokanson Strain Gauge Technology 
Forearm and calf blood flow.  Forearm blood flow (FBF) and calf blood flow (CBF) will 
be measured using mercury-filled strain-gauge plethysmography (EC-6, D.E. Hokanson, 
WA), as previously described.  Briefly, a cuff will be placed around the upper left arm 
and thigh, a strain gauge around the widest part of the forearm and calf, and an 
additional cuff around the wrist and ankle to occlude hand and foot circulation, 
respectively, the wrist and ankle cuffs will be inflated and held at 50 mmHg above SBP 
for one minute.  Arm and thigh cuffs will be inflated to 50mmHg for 7 seconds, 
followed by 8 seconds deflation, during a 15-second cycle, as previously described.  The 
plethysmographic signal will be captured by a digital recorder for later analysis (BioPac 
Systems, CA).  An average of six cycles will be used for analysis of FBF and CBF and will 
be expressed as milliter per minute per 100 ml of calf/forearm tissue. 
Bio Pac systems 
Heart Rate Variability (HRV) with head-up tilt. A modified CM5 ECG lead will be used 
to collect continuous R-R intervals (resolution of 1 ms) “on-line” in real time, and will 
stored on the computer (BioPac Systems, CA) for later analysis by Heart Signal software 
(Oulu, Finland).  During all HRV data collection, paced breathing (12 breaths/minute) 
will be employed.  The subject will be allowed to rest supine for 10 minutes and then 
will be tilted to 80 degrees for 10 minutes followed by a return to supine for 10 
minutes of recovery data.  The R-R intervals will be visually inspected and then filtered 
by the HRV software to eliminate undesirable noise or premature beats.  The filtering 
and analysis of the R-R intervals will be conducted according to procedures described 
by Huikuri et al.  Any R-R interval that deviates more than 30% from the previous 
interval will be considered premature.  Following filtering, only those recordings in 
which less than 2% of beats are filtered will be included in HRV analysis.  In the time 
domain, the standard deviation of all R-R intervals (SDNN), and the square root of the 
mean squared differences of successive R-R intervals, (RMSSD) will be determined at 
rest and after exercise.  In addition, the percentage of R-R intervals that deviate more 
than 50 ms from the previous R-R interval (Dev>50) will be calculated.  Power spectrum 
densities of HRV will be calculated for high-frequency (HF, 0.15-0.40 Hz) and low-
frequency (LF, 0.04-0.15 Hz) components and the LF/HF ratio during rest and after 
exercise.  An autoregressive model will be used to determine LF and HF power as 
previously described by Tulppo et al.  The power spectral densities are calculated in 
both absolute and normalized (nu) units (normalize to total spectral power).  All data 
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acquisitions and post-acquisition analyses will be carried out in accordance with the 
standards put forth by the Task Force on heart rate variability interpretation. 
Hokanson Strain Gauge Technology 
Vasodilatory Capacity of the Forearm.  Vasodilatory capacity will be assessed in the 
forearm using reactive hyperemia (RH), as previously described.  A blood pressure cuff 
placed around the upper left arm will be inflated to pressure 100 mmHg above SBP, 
occluding arterial inflow for 5-minutes.  One minute prior to release of the cuff, a wrist 
cuff will be inflated to 50 mmHg above SBP.  After rapid release of the arm cuff, FBF 
will be measured for 3-minutes, as described above.  The plethysmographic signal will 
be captured by a digital recorder for later analysis (BioPac Systems, CA). 
Cardiac Output (CO) and Total Peripheral Resistance (TPR).  Co and TPR will be derived 
from beat-to-beat arterial waveforms, using Modelflow, as previously described.  This 
method has been shown valid and reliable under resting conditions. 
Approximately 3 days will elapse between subject visits to ensure all physiological adaptations have 
returned to baseline (Monday and Thursday will be assessment days).   
Full instructions for the behavioral experiments are included as an attachment.  The set of 
experiment tasks will include 3 distinct individual decision tasks, to be administered to subjects at 
baseline, following their midday exercise episode, and on the final day of the study (return to 
baseline).  The tasks involve a “lottery choice task”, a “Bayes rule task” and a “Delayed reward” task.  
Real monetary incentives are at stake on each administration (i.e., each day) of the set of tasks.  The 
Bayes and lottery choice tasks will be administered on a laptop computer (as these tasks are already 
programmed and being utilized as part of an existing IRB approved study), and the Time delay tasks 
will be administered paper and pencil.  The short descriptions of each are: 
BEHAVIORAL EXPERIMENT ADMINISTRATION 
This task examines how individuals make decisions based on prior information and new information 
about an event’s likelihood.  The decision to be made by the subject is whether an observed series 
of “draws” from an unknown box came from the Box on the Left or the Box on the Right.  Both the 
prior odds as well as the sample variation vary across trials, such that the decisions range from 
relatively easy to difficult.  One trial will be randomly selected from all trials, and subjects will be 
compensated $10 in the event that their choice was correct for that trial (otherwise, payoff is zero 
for this task). 
Bayes Rule task (BR instructions) 
In this task, subjects indicate their preferences of one gamble (or “risky event”) over another.  Each 
trail contains a relatively safer gamble and a relatively riskier gamble, thought the expected payoff 
Lottery Choice task (LC instructions) 
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of each gamble is the same.  One block of treatments includes only gambles of monetary gains, 
while the other includes only gambles over monetary losses.  A randomly selected trial will be made 
from each block (gains and losses), and for the randomly selected trial, the gamble that was chosen 
as preferred by the subject will be played out for their actual monetary payoff.  Thus, the subject’s 
monetary payoff for this task will include a gain as well as a loss.  The loss amount will be subtracted 
from the subject’s overall decision task earnings in the event the loss outweighs the gain for this 
task. 
This task will ask subjects to indicate preference over receiving different amounts of money sooner 
rather than a larger amount of money later.  The amounts of money, percent difference in monetary 
amounts, and time delay variables will differ across trials.  One trial will be chosen at random, and 
the subject will receive his/her choice for that trial.  Notice, this trial has a payoff to the subject that 
may take place the day of the experiment, or possibly 2 or 4 weeks into the future.  The instructions 
make this clear to the subject, and payoffs for this task will be in the form of a check mailed to the 
subject on the specified day. 
Time delay task (TD instructions) 
4.  Is deception involved?   YES _____     NO __X___ 
     If yes, please describe. 
5.  Does the data to be collected relate to any illegal activities (e.g. drug use, abuse, assault)?     
      YES_____     NO_X____ 
       If yes, please explain. 
6.  The benefits of this activity to the participants must outweigh the potential risks.  To this end, 
please: 
a.  Describe the benefits to the individual participants and to society. 
 Knowledge of exactly how blood pressure responds to exercise throughout the day will 
allow us to efficiently train at the optimal time of day in order to achieve the nocturnal blood 
pressure changes throughout sleep.  Achievement of dipping blood pressure status reduces the 
instance for cardiac events and may provide knowledge that could provide a longer lifespan.  
Further, it is possible that resting blood pressure may decrease in response to the exercise bout.  
 For each individual subject, each subject will gain knowledge about their present fitness 
level, their sleep architecture, and each will receive a personalized exercise prescription.  Also, each 
subject will be compensated when they finish the behavior analyses questionnaires (with average 
compensation including a fixed $35 payment and a variable pay component that depends on 
decisions made in the experiment).  We anticipate setting variable pay incentives so that total 
monetary compensation of subjects in the study will be $60-$99 (with $35 guaranteed).  The fixed 
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payment will not be paid until the end of the study, but subjects will receive the remaining decision 
experiment compensation as it is earned and determined by the subject’s decisions. 
b.  Describe the potential risks to any individual participating in this project.  Please explain 
any possible risks of psychological, legal, physical, or social harm.  What provisions have been made 
to insure that appropriate facilities and professional attention necessary for the health and safety of 
the participants are available and will be utilized? 
Exercise Testing:  The risks associated with exercise testing include increased blood pressure and 
possible heart arrhythmias (abnormal heart beats). There is a very small risk of heart attack during 
exercise testing/training.  To minimize this risk we have the subjects complete a medical history 
questionnaire showing a history for these individuals.  Further, all maximal exercise testing will be 
supervised by a trained clinical exercise physiologist.  Although the electrocardiogram (ECG) poses 
minimal risk, occasionally a person allergic to the adhesive electrodes may develop a local irritation.  
Lastly, individuals may experience localized fatigue or muscle soreness especially after their initial 
workout sessions, however this soreness will dissipate within 24-48 hours post exercise.  Rest breaks 
will be incorporated into the training to help minimize possible muscle soreness associated with 
exercise training. 
Body Composition Testing: There are no known risks associated with this measure.  It is essentially 
the same as stepping on a bathroom scale at home.   
Reactive Hyperemia:  No substantial risks are associated with reactive hyperemia.  Subjects may feel 
some discomfort in their arm during the occlusion portion of the test.  The sensation is similar to the 
"pins and needles" individuals feel if their arm "falls asleep." This feeling will immediately disappear 
once the occluding pressure cuff is released and blood flow returns to normal.  This is a common 
technique employed to determine vascular function, and 5 minutes of occlusion is the minimum 
amount of time needed to yield accurate measures.  No tissue damage is associated with this 
method. 
Pulse wave velocity:  There are no known risks associated with the Doppler ultrasounds used in this 
technique.  A small Doppler sensor will be placed on the surface of the skin against the carotid 
artery, radial artery, femoral artery and the dorsalis pedis (ankle).  The signal probe uses ultrasound 
to measure the direction and speed of blood blow through an artery. No physical disomfort should 
be experienced during this assessment.  Patient privacy will be upheld with great care during the 
assessment of the femoral artery, as this is located near the pubic area.  
Electrocardiography (ECG):  There are no known risks associated with standard ECG. Trained 
technicians will perform all ECG preparation and measurements. Again, care will be taken to uphold 
patient privacy during preparation and assessments, as the chest area will need to be somewhat 
exposed for electrode placement. 
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Blood Pressure Assessment: There are no known risks associated with finger plethysmography or 
ABPM.  A small cuff is placed around the idex finger or the biceps and it is inflated similar to an arm 
blood pressure cuff.  Subjects may feel slight discomfort in their finger with this cuff  but this will 
disappear almost immediately when the cuff is released.  A trained technician will demonstrate and 
fit the cuff for each subject. 
Ambulatory Sleep Monitoring:  Minor risk of discomfort is possible wearing the actigraphy of soft-
fabric ZeoTM headband.  Because the back side of the actigraphy is metal and because metallic fibers 
are used in the ZeoTM headband to transmit brainwave data, there is risk of skin rash or reaction in 
individuals who may be allergic to metals.  Subjects will be informed to remove either device in such 
a case and contact one of the investigators. 
7.  Please describe how participants will be informed of their rights and how informed consent will 
be obtained and documented.  Attach a copy of the consent form and any materials used in the 
recruitment of participants. 
Participant will be informed of their rights by written (informed consent) and verbal explanation.  All 
questions regarding the issue of participant rights will be addressed before obtaining informed 
consent.  Any questions that arise after consenting to the study will be addressed before 
continuation of the procedures. 
8.  The confidentiality of all participants must be maintained.  To this end, please respond to the 
following. 
Like any study, participation will involve some loss of privacy, but the information collected from 
each subject will be handled as confidentially as possible.  The individuals file and hardcopy data will 
be locked in a file cabinet within a locked office in a secure building and each data file will be 
encoded without the individuals name to associate it.    
 b.  How will confidentiality of data be maintained? 
   Also, the data will be coded and entered into a computer spreadsheet and all  
  individual identifiers will be removed.   
 c.  Describe the process of final disposition of the data.  How long will the data be stored 
 and how will they be destroyed? 
Data will remain secured in a locked office, and/or on investigators’ harddrives.  As 
noted above, individual identifiers will be destroyed from the secondary data set once the 
data has been properly organized into its final spreadsheet form.  This guarantees that 
subjects will never be identified in any dissemination of the data (e.g., presentations, 
papers, etc.).   
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d. How are participants protected from the future harmful use of the data collected in this 
 protocol? 
 All data will be used only for the purpose of this study and no data will be shared 
  with anyone outside the immediate study team.  Further, all study data on  
  computer files will be decoded so there will be no identifying features left on the 
  spreadsheets. 
 
*The study team consists of: 
PI’s - Scott R. Collier, PhD, David Dickinson, PhD. 
Research Assistants: 
Ben Cartner, B.S. 
Kimberly Fairbrother, B.S. 
Jeff Soukupt, PhD 
Cate Trate, MD 
Carol Cooke, MS 
All of the study team will have their CITI training completed prior to the start of this study 
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Appalachian State University 
Informed Consent for Participants in 
Research Projects Involving Human Subjects 
 
Title of Study: The Effect of Aerobic Exercise on Behavior and Nocturnal Blood Pressure Response in Pre-
Hypertensive Individuals 
You are being asked to participate in a research study because you are a healthy male or female between 30 
and 60 years of age, with no diabetes, kidney or heart problems, no history of stroke, and on no medications 
and have been diagnosed with untreated pre-stage 1 essential hypertension (high normal blood pressure).  
Dr.’s David Dickinson and Scott Collier (Departments of Economics and Health, Leisure and Exercise Science at 
Appalachian State University) are conducting this study.    
Background/Purpose: 
Blood pressure (BP) and the incidence of hypertension increases with age. Hypertension is the most prevalent 
cardiovascular disease that afflicts the elderly population and hypertension-associated cardiovascular disease 
is the leading cause of morbidity and mortality in the Western world.  It is well established that nocturnal 
dipping of blood pressure is a healthy adjustment and helps reset the body’s sensitivity to their blood pressure 
range.  Clinically, if an individual with resistant hypertension does not realize a dip in blood pressure at night, 
they show an exponential increase in mortality and morbidity and a decrease in life expectancy. 
We will study the effects of aerobic exercise performed at preset times during the morning, noon and evening, 
to determine which time is best suited for exercise based on your night-time blood pressure response.  
The purpose of this study is to examine the potential changes on nocturnal blood pressure in men and women 
following aerobic exercise training during a specific time of day.  In addition we are interested in examining 
how aerobic exercise affects your body’s ability to change blood pressure, heart rate and blood vessel size.  A 
final objective of this study is to evaluate whether decision making is effected following a bout of moderate 
aerobic exercise. 
If you have a known cardiovascular heart disease, such as congenital heart disease, hypertrophic 
cardiomyopathy, complex supraventricular or ventricular dysrhythmias at rest or dysrhythmias that worsen 
with exercise, this study may not be appropriate for you.  The remainder of this form will explain the study in 
greater detail.  If you have any questions, please ask the study personnel that gave you this form. 
If you choose to participate, you will be asked: 
Study Procedures: 
1. To report to the Institute for Health and Human Services (IHHS) at Appalachian State University 
(Room 068C, University Hall Rd) on 4 separate occasions for 1 to 1.5 hours per visit for exercise 
measures. 
2. To wear a small, mobile, blood pressure monitor that will record your blood pressure at 20 minute 
intervals for the 24-hour period following your scheduled aerobic exercise. 
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3. To wear both a wrist-based actigraphy (like wearing a wrist watch) on your non-dominant wrist and a 
soft headband during your attempted nightly sleep episode the evening following your scheduled 
aerobic exercise. 
 
At visit 1 (Initial visit) 
The morning of your initial visit, you will report to the IHHS, Rm 71, on University Hall Rd. 
During this visit, you will be familiarized with the study instruments and procedures in the Research 
Laboratory.  You will also be randomized into the group that will determine what time of day you will begin 
the training regimen.  You will exercise during the morning time (7-8am),  noon time (12-1pm), or evening (6-
7pm).  Your exercise times will be randomized during the first visit and we will give you a schedule for all your 
appearances at the laboratory. You will be asked to answer a medical and exercise history questionnaire. You 
will be administered a set of decision experiments, and then we will measure your height, weight, baseline 
blood pressure and evaluate your cardio-respiratory fitness as described below. 
Graded exercise test
Visits 2-4 
: You will be evaluated for cardio-respiratory fitness using the graded exercise test on a 
treadmill. In this test, you will start walking on a treadmill at about 2.5 miles per hour and every 2 minutes the 
speed or grade will be increased slightly until you get tired. This test is designed to make you tired in about 10 
to 12 minutes. You will be wearing a facemask (so that we can collect and analyze your expired air) and a heart 
rate monitor to measure your heart rate. This test will determine your maximum oxygen consumption (VO2) 
which is your ability to take oxygen out of the air, to the working muscles. This will help us determine the 
correct starting point for your aerobic exercise prescription.  
At these visits you will be asked to undergo a similar exercise test for 30 minutes at 65% of your peak VO2 
established during the initial visit.  The aerobic exercise will consist of walking and jogging on the treadmill.  
Qualified clinical staff will be present at all exercise performances.  On your randomly chosen noon time 
exercise day (could be day 2, 3, or 4), you will be administered the set of decision experiments immediately 
following your bout of exercise. 
Risks
The risks and discomforts involved with participating in this study are: 
: 
Exercise testing
Individuals may experience localized fatigue during the exercise testing/ training, and possibly some muscle 
soreness after the exercise testing/training.  This should subside within 24-48 hours after testing.  Soreness is 
rare in normal, healthy individuals.  Rest breaks will be incorporated into the training to help minimize 
possible soreness associated with exercise training. We will also try to minimize this risk by taking you through 
a series of light stretches after testing is completed.  
:  The risks associated with exercise testing include increased blood pressure and possible 
heart arrhythmias (abnormal heart beats).  There is a very small risk of a heart attack during the exercise 
testing and training.   To minimize this risk, we will have you answer questions regarding your medical history 
and family history to screen for any significant heart disease that might exist without any symptoms.  
Another possible risk may be abnormal changes in your heart rate and blood pressure.  We will attempt to 
minimize this risk by carefully monitoring your heart rate and blood pressure responses during aerobic 
39 
 
training.  Any male greater than 45 years of age and any female greater than 50 years of age will have their 
heart rate and EKG monitored. 
Blood pressure assessment:  There may be slight discomfort due to pressure felt in the upper arm that the 
cuff is placed on. However, this slight pressure is only felt for about one minute while the measurement is 
being taken. 
Ambulatory sleep monitoring:  There may be minor risk of discomfort from wearing the wrist-device and/or 
soft headband during your attempted nightly sleep.  Both devices contain metal, and so there is a minor risk of 
allergic reaction if your skin reacts to metals. 
Answering Questionnaires should not pose any risk to you. 
Decision Experiments:
The investigators involved in this project have extensive experience in exercise testing, which should minimize 
the above risks. 
  There may be minor risk of dissatisfaction with your monetary payoffs from these 
decision tasks, though average compensation is set to be satisfactory for most participants. 
You will benefit from having a personal fitness assessment. You will receive information about your current 
aerobic or muscular fitness level.  Additionally, you will receive information on how well your heart and blood 
vessels respond to exercise training during specific times during the day.  Finally, you will receive information 
on your sleep during the nights you wore the ambulatory sleep devices (information on both total sleep time 
as well as stages of deep, light, and REM sleep). 
Benefits: 
In addition to the health related information you will be provided (described above), you will be compensated 
a guaranteed $35 for participation in this study (i.e., all 4 days of the study), payable on the last day of the 
study.  You will also earn a variable amount of money (over and above your $35 minimum) as a result of your 
actual decisions in the decision experiments.  Because this component of your monetary compensation for 
this study depends on the decisions you make in the decision tasks, we cannot tell you in advance how much 
this will be.  However, we will say that a variable compensation opportunity is available on each of the 
experiment days where decision tasks are administered.  The level of the variable compensation will be set so 
that average variable compensation will be approximately $55 per subject.  Thus, TOTAL monetary 
compensation from this study will average about $90 per subject.  This means that some subjects will earn 
more than $90 monetary compensation, some will earn less than $90 monetary compensation, but no one will 
receive less than $35 monetary compensation.             
Monetary Compensation: 
You will need to provide your address and your Banner ID or your social security number for compensation. 
The information learned may also help others in the future.  
Your participation in this study is entirely voluntary and you may refuse to participate or discontinue 
participation at any time without penalty or loss of benefits to which you would normally be entitled. Your 
Voluntary Participation: 
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decision about whether or not to participate in the study will not affect your relationship with Appalachian 
State University. 
 
You are free to choose not to participate in this study. 
Alternatives: 
In addition to the health related information you will be provided (described above), you will be compensated 
a guaranteed $35 for participation in this study.  You will also earn a variable amount of money (over and 
above your $35 minimum) as a result of your actual decisions in the decision experiments.   
Costs/Payments: 
If you have any questions about the research, or in the event of a research-related injury, please contact Dr. 
Scott Collier at (828) 262-7145 or Dr. David Dickinson at (828) 262.7652. If you have any questions about your 
rights as a research subject, please contact Dr. Tim Ludwig at the Appalachian State University Institutional 
Review Board Office at (828) 262-2692. 
Questions: 
In the event of illness or physical injury resulting from taking part in this research study, medical treatment will 
be provided at Watauga Medical Hospital. You will be responsible for any costs not paid by your insurance 
company. No other compensation is offered by Appalachian State University. We have no plans to give you 
money if you are injured. You have not waived any of your legal rights by signing this form. 
In Case Of Injury: 
If you agree to participate in this research, identifiable health information about you will be used and shared 
with others involved in this research. For you to be in this research we need your permission to collect and 
share this information. Federal law protects your right to privacy concerning this information.  
Confidentiality of Records and Authorization to Use/Share Protected Health Information for Research: 
When you sign this consent form at the end, it means that you have read this section and authorize the use 
and/or sharing of your protected health information as explained below.  
Individually identifiable health information under the federal privacy law is considered to be any information 
from your medical record, or obtained from this study, that can be associated with you, and relates to your 
past, present, or future physical or mental health or condition. This is referred to as protected health 
information. 
Your protected health information will be kept confidential. Your identity will not be revealed in any 
publication or presentation of the results of this research. 
Why is it necessary to use/share your protected health information with others? 
The main reason to use and share your health information is to conduct the research as described in this 
consent form. Your information may also be shared with people and organizations that make sure the 
research is being done correctly, and to report unexpected or bad side effects you may have. 
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In addition, we may be required by law to release protected health information about you; for example, if a 
judge requires such release in a lawsuit, or if you tell us of your intent to harm yourself or others. 
What protected health information about you will be used or shared with others as part of this research? 
We may use and share the results of tests, questionnaires, and interviews. We may also use and share 
information from your medical and research records. We will only collect information that is needed for the 
research. 
Who will be authorized to use and/or share your protected health information? 
The researchers will use your protected health information for this research study. In addition, the 
Appalachian State Institutional Review Board (IRB) committee responsible for protecting the rights of research 
subjects who supervise the way the research is done may have access to your protected health information.  
The researchers and their staff will determine if your protected health information will be used or shared with 
others outside of Appalachian State University for purposes directly related to the conduct of the research.  
With whom would the protected health information be shared? 
Your protected health information may be shared with: 
• Federal agencies that supervise the way the research is conducted, such as the Department of Health and 
Human Services’ Office for Human Research Protections, or other governmental offices as required by law.   
• If so desired, you can request your information be shared with your primary care physician 
All reasonable efforts will be used to protect the confidentiality of your protected health information. 
However, not all individuals or groups have to comply with the Federal privacy law. Therefore, once you’re 
protected health information is disclosed (leaves Appalachian State University); the Federal privacy law may 
not protect it.   
For how long will your protected health information be used or shared with others? 
There is no scheduled date at which this information will be destroyed or no longer used. This is because 
information that is collected for research purposes continues to be used and analyzed for many years and it is 
not possible to determine when this will be complete. 
Can you withdraw your authorization to collect/use/share your protected health information? 
You always have the right to withdraw your permission (revoke authorization) for us to use and share your 
health information, by putting your request in writing to the investigator in charge of the study.  This means 
that no further private health information will be collected.  
Even after you withdraw your permission, Appalachian State University may continue to use and share 
information needed for the integrity of the study; for example, information about an unexpected or bad side 
effect you experienced related to the study.  
Can you have access to your health information? 
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At the end of the study, you have the right to see and copy health information about you in accordance with 
the Appalachian State University policies; however, your access may be limited while the study is in progress.  
 
 
 
I have read and understand the Informed Consent and conditions of this project. I have had all my questions 
answered. I hereby acknowledge the above and give my voluntary consent:  
Consent To Participate In Research & Authorization To Use And Share Personal Health Information: 
 
_________________________________________________Date__________  
Subject signature  
 
________________________________________________ Date __________  
Witness (Optional except for certain classes of subjects)  
 
Should I have any questions about this research or its conduct, I may contact:  
 
  Investigators Telephone/e-mail  
David Dickinson at 828.262.7652  or email him at  dickinsondl@appstate.edu  
 
  Investigators  Telephone/e-mail 
Scott Collier at 828.262.7145 or email him at colliersr@appstate.edu  
Administrator,    IRB Telephone  e-mail  
Tim Ludwig, PhD   828-262-2692   irb@appstate.edu  
 
 
Graduate Studies and Research  
Appalachian State University  
Boone, NC 26608 
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PRE-EXERCISE MEDICAL HISTORY FORM 
 
All information given is confidential.  It will enable us to better understand you and your health and fitness 
habits. 
 
Name. _______________________________Date: ______________ 
Birthdate: _______________   Age: ______ 
Height: ______________   Weight: ________ 
 
Address: _______________________________________________________ 
 
   ______________________________________________________ 
 
Phone Numbers: Home: ____________________Other: __________________ 
 
 
Health History Questionnaire 
    
   Yes        No 
Do you ever get chest pains while at rest and /or during exertion?   ____    ____ 
If yes, has a physician diagnosed these pains?     ____    ____ 
             
Have you ever had a heart attack?        ____    ____                           
If yes, was your heart attack within the last year?      ____    ____ 
            
Do you have high blood pressure (i.e., a reading of more than 150 / 100)?  ____    ____                          
If yes, is your high blood pressure currently                                          
      
Have you ever been diagnosed with high cholesterol?  ____    ____ 
  
Do you lose your balance because of dizziness or do you ever lose  ____    ____ 
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consciousness?          
 
Are you currently being treated for any heart or circulatory condition, such  ____   ____               
as vascular disease, stroke, angina, hypertension, congestive heart failure, 
poor circulation, valvular heart disease, blood clots, or pulmonary disease?   
    
Have you ever been diagnosed with a spinal problem or do you experience ____   ____ 
frequent low back pain?         
 
Has your physician ever specifically told you not to do “heavy” or “hard”  ____   ____ 
exercise?           
Do you know of any other reason
 
 why you should not do physical activity?   ____   ____ 
Medical History 
Do you have or have you ever had:  (check if yes) 
 
____ heart murmur    _____ arthritis 
____ extra/skipped heart beats   _____ asthma 
____ chest pain or pressure   _____ bronchitis 
____ high blood pressure    _____ cancer 
____ heart attack    _____ diabetes 
____ stroke     _____ emphysema 
____ leg cramps     _____ epilepsy 
____ varicose veins    _____ pneumonia 
____ dizziness/fainting    _____ rheumatic fever 
____ back pain     _____ scarlet fever 
____ shortness of breath    _____ surgery 
____ injuries to back, knees, ankles   _____ joint pain 
 
Explanations/Commments/Descriptions:_________________________________________________________
______________________________________________________ 
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Other diseases/injuries/medical problems that we should be aware of: 
__________________________________________________________________________________________
__________________________________________________________________________________________ 
 
Medicines/Drugs you are now taking (please list 
dosages):______________________________________________ 
__________________________________________________________________________________________ 
 
Family History 
 
Please indicate the number 
 
of blood relative (mother, father, grandparents, siblings who have or have had 
the following: 
 Heart attack or stroke before age 50  _______ 
 Heart attack or stroke after age 50   _______ 
 Congenital heart disease    _______ 
 Heart operations     _______ 
 High blood pressure    _______ 
 Diabetes     _______ 
 Substantially overweight    _______ 
 High cholesterol levels    _______ 
 
Remarks: 
_____________________________________________________________________________________ 
__________________________________________________________________________________________ 
 
Present Symptoms Review 
Do you ever experience any of the following during exercise? 
______ Chest pain 
______ Shortness of breath 
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______ Heart palpitations 
______ Cough on exertion 
 
Health Inventory 
 
Smoking Habits 
Do you smoke cigarettes at present?  Yes ______  No _____ 
 If yes, how many per day?        <1/2 pack ______        1/2 to 1 pack _____ 
         1 - 2 packs ______       >2 packs _____ 
 
Did you smoke cigarettes in the past and quit permanently?  Yes _____   No ______ 
 How may years has it been since you quit?             ______ 
 How many packs per day were you smoking before you quit?          ______ 
 How many years did you smoke before you quit?            ______ 
 
I certify that I have read, understood, and completed this questionnaire.  Any questions I had were answered 
to my satisfaction. 
 
 
           
Participant’s Name     Today’s Date 
 
 
        
Participants Signature    
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